Paper3027853
Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies.
Tricot G and 4 others. Rev Infect Dis, 1987. Cited by 157 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies. Papers, record 3027853. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3027853
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Agranulocytosis | Major topic |
| Antifungal Agents | Major topic |
| Ketoconazole | Major topic |
| Mycoses | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Anemia, Aplastic | |
| Aspergillosis | |
| Blast Crisis | |
| Child | |
| Female | |
| Humans | |
| Itraconazole | |
| Leukemia, Lymphoid | |
| Leukemia, Myeloid | |
| Leukemia, Myeloid, Acute | |
| Lymphoma, Non-Hodgkin | |
| Male | |
| Middle Aged |
Source PubMed
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 157 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37311136 | Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). | J Antimicrob Chemother | 2023 | https://conductscience.org/library/papers/37311136 | PubMed |
| 34370587 | Population Pharmacokinetics and Pharmacodynamics of Itraconazole for Disseminated Infection Caused by Talaromyces marneffei. | Antimicrob Agents Chemother | 2021 | https://conductscience.org/library/papers/34370587 | PubMed |
| 33468480 | Variability of Hydroxy-Itraconazole in Relation to Itraconazole Bloodstream Concentrations. | Antimicrob Agents Chemother | 2021 | https://conductscience.org/library/papers/33468480 | PubMed |
| 32383061 | Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper. | Intensive Care Med | 2020 | https://conductscience.org/library/papers/32383061 | PubMed |
| 30197526 | Trough concentration of itraconazole and its relationship with efficacy and safety: a systematic review and meta-analysis. | Infect Drug Resist | 2018 | https://conductscience.org/library/papers/30197526 | PubMed |
| 25587296 | Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspective. | Can J Infect Dis Med Microbiol | 2014 | https://conductscience.org/library/papers/25587296 | PubMed |
| 24379304 | Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology. | J Antimicrob Chemother | 2014 | https://conductscience.org/library/papers/24379304 | PubMed |
| 22346497 | Itraconazole: Precautions regarding drug interactions and bioavailability. | Can J Infect Dis | 1994 | https://conductscience.org/library/papers/22346497 | PubMed |
| 22171289 | Investigation of microemulsion system for transdermal delivery of itraconazole. | J Adv Pharm Technol Res | 2011 | https://conductscience.org/library/papers/22171289 | PubMed |
| 19857383 | What is the role of therapeutic drug monitoring in antifungal therapy? | Curr Infect Dis Rep | 2009 | https://conductscience.org/library/papers/19857383 | PubMed |
| 19472033 | Drug interaction between oral solution itraconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplantation recipients: an association with bioavailability of oral solution itraconazole. | Int J Hematol | 2009 | https://conductscience.org/library/papers/19472033 | PubMed |
| 19066334 | Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. | Haematologica | 2009 | https://conductscience.org/library/papers/19066334 | PubMed |
| 18955533 | Antifungal therapeutic drug monitoring: established and emerging indications. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/18955533 | PubMed |
| 15247932 | A pilot study of targeted itraconazole prophylaxis in patients with graft-versus-host disease at high risk of invasive mould infections following allogeneic stem cell transplantation. | Bone Marrow Transplant | 2004 | https://conductscience.org/library/papers/15247932 | PubMed |
| 11296129 | Therapy for fungal infections in leukemia. | Curr Oncol Rep | 2001 | https://conductscience.org/library/papers/11296129 | PubMed |
| 10073735 | The therapeutic monitoring of antimicrobial agents. | Br J Clin Pharmacol | 1999 | https://conductscience.org/library/papers/10073735 | PubMed |
| 9884817 | Optimisation of itraconazole therapy using target drug concentrations. | Clin Pharmacokinet | 1998 | https://conductscience.org/library/papers/9884817 | PubMed |
| 9227863 | Antifungal prophylaxis during neutropenia and immunodeficiency. | Clin Microbiol Rev | 1997 | https://conductscience.org/library/papers/9227863 | PubMed |
| 8534764 | Aggravation of vincristine-induced neurotoxicity by itraconazole in the treatment of adult ALL. | Ann Hematol | 1995 | https://conductscience.org/library/papers/8534764 | PubMed |
| 8261715 | Pharmacokinetic optimisation of oral antifungal therapy. | Clin Pharmacokinet | 1993 | https://conductscience.org/library/papers/8261715 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3027853
GET https://conductscience.org/api/papers/v1/3027853/cited_by?page=2